510(k) K010389
K010389 is an FDA 510(k) premarket notification submitted by Chad Therapeutics, Inc. for the device "CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411". The FDA issued a decision of Substantially Equivalent on Mar 23, 2001. The device falls under product code NFB (Conserver, Oxygen), a Class II device regulated under 21 CFR 868.5905. Chad Therapeutics, Inc. has 16 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 23, 2001
- Date Received
- Feb 9, 2001
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Conserver, Oxygen
- Device Class
- Class II
- Regulation Number
- 868.5905
- Review Panel
- AN
- Submission Type
- 510(k)
Need the full FDA record for Chad Therapeutics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.